股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 江蘇創新環保新材料有限公司 呈交日期: 2026年2月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02116 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | 本月底法定/註冊股本總額： HKD 15, ...

上市公司：钱江摩托（000913），信隆健康（002105），征和工业（003033），久祺股份（300994）， 林海股份（600099），上海凤凰（600679），中路股份（600818），力帆科技（601777），春风动力 （603129），爱玛科技（603529），隆鑫通用（603766），永安行（603776），新日股份（603787）， 绿通科技（301322），涛涛车业（301345），华洋赛车（834058） 相关报告：智研咨询发布的《2026-2032年中国摩托车行业市场全景评估及发展策略分析报告》 根据中国汽车工业(摩托车)产销快讯数据显示：2025年12月江苏创新摩托车制造有限公司摩托车产量为 4000辆，同比下降6.98%，销量为3960辆，同比下降18.16%，产销率为99%，积压40辆；2025年1-12月 江苏创新摩托车制造有限公司摩托车产量为28850辆，产量累计同比下滑15.27%，2025年1-12月江苏创 新摩托车制造有限公司销量为28231辆，销量累计同比下滑9.63%。 近一年江苏创新摩托车制造有限公司摩托车产销情况统计图 数据来源：中国汽车工业(摩托车)产销快讯，智 ...

Core Insights - The trade cooperation between China and Central Asia is reaching new heights, with the total import and export volume expected to reach $106.3 billion by 2025, reflecting a year-on-year growth of 12% and an increase of 6 percentage points from the previous year [1] Group 1: Trade Platform Development - The "China-Central Asia Trade Facilitation Cooperation Platform" was established in Nanjing in June 2025, attracting over 20 Central Asian institutions, serving as a one-stop hub for trade connections [1] - The platform has facilitated trade intentions worth several hundred million dollars in agricultural and mineral products between China and Kazakhstan [2] - The platform's online component, "Suhao Cloud," has onboarded over 550 domestic companies, enabling Jiangsu-made products to reach Central Asian consumers [2][3] Group 2: Trade Growth and Economic Impact - Jiangsu's import and export volume with the five Central Asian countries is projected to reach 35.32 billion yuan in 2025, marking a year-on-year increase of 12.6% [3] - Companies like Changshu Longte Wear-resistant Ball Co., Ltd. have significantly increased exports to Central Asia, with a reported value exceeding 478 million yuan [4] - The logistics channels and platform services have enhanced trade efficiency, leading to a notable rise in export activities from Jiangsu to Central Asia [3][4] Group 3: Cultural and Educational Exchange - The platform has evolved into a multi-faceted bridge, hosting events like the Jiangsu-Central Asia Youth Friendship Association, which attracted nearly 120 students from 10 countries [5] - A Central Asia Publishing Center was established to facilitate cultural exchanges through book translations, enhancing cooperation in cultural publishing [5] Group 4: Innovative Trade Practices - The 2025 Jiangsu (Astana) Import and Export Commodity Exhibition saw over 60 Jiangsu enterprises sign contracts worth 800 million yuan, showcasing the effectiveness of trade networking [6] - The number of Jiangsu-Central Asia freight trains has increased to 1,420 in 2025, reflecting a year-on-year growth of 9.3% [6] Group 5: Future Development Plans - The platform aims to deepen regional economic cooperation and establish the "Central Asia Jiangsu Center" in Astana, promoting trade exhibitions and educational collaborations [7] - Plans are in place to create a national digital trade demonstration zone and enhance cross-border payment systems to facilitate trade [7]

Core Viewpoint - As of January 15, a total of 105 stocks reached their 52-week highs, with notable performers including 德莱建业 (01546), 东曜药业－Ｂ (01875), and 大森控股 (01580) achieving high rates of 78.00%, 51.36%, and 37.61% respectively [1]. Summary by Category 52-Week Highs - 德莱建业 (01546) closed at 0.355, with a peak of 0.445, marking a high rate of 78.00% [1]. - 东曜药业－Ｂ (01875) closed at 4.190, reaching a high of 4.450, with a high rate of 51.36% [1]. - 大森控股 (01580) closed at 0.275, with a peak of 0.300, achieving a high rate of 37.61% [1]. - 顺兴集团控股 (01637) and 怡园酒业 (08146) also showed significant increases, with high rates of 36.36% and 24.74% respectively [1]. Additional Notable Stocks - JBB BUILDERS (01903) reached a high rate of 24.12% with a closing price of 2.830 [1]. - 天臣控股 (01201) and 江苏创新 (02116) had high rates of 15.38% and 15.00% respectively [1]. - 万国黄金集团 (03939) and 竣球控股 (01481) also performed well, with high rates of 12.95% and 12.44% respectively [1]. 52-Week Lows - The report also noted stocks reaching 52-week lows, with 天彩控股 (03882) showing a low rate of -14.42% [3]. - 中国智慧能源 (01004) and 基石控股 (01592) followed with low rates of -13.64% and -12.86% respectively [3]. - 弘毅文化集团－旧 (02990) and 中原建业 (09982) also reported significant declines of -9.09% and -6.06% respectively [3].

Group 1 - The core viewpoint of the article highlights the declining production and sales figures in the motorcycle industry, specifically focusing on Jiangsu Innovation Motorcycle Manufacturing Co., which experienced a significant drop in both production and sales in November 2025 [1] - Jiangsu Innovation Motorcycle Manufacturing Co. produced 2,700 motorcycles in November 2025, representing a year-on-year decrease of 43.16%, while sales were 2,371 units, down 40.08% year-on-year [1] - The production-sales ratio for Jiangsu Innovation Motorcycle Manufacturing Co. stood at 87.81%, with an inventory backlog of 329 units [1] Group 2 - The article references a report by Zhiyan Consulting titled "2026-2032 China Motorcycle Industry Market Panorama Assessment and Development Strategy Analysis Report," indicating ongoing research and analysis in the motorcycle sector [1] - The data presented is sourced from the China Automotive Industry (Motorcycle) Production and Sales Quick Report, which provides insights into the current state of the motorcycle market [1] - Zhiyan Consulting is described as a leading industry consulting firm in China, specializing in in-depth industry research reports, business plans, feasibility studies, and customized services [1]

Core Viewpoint - The "Talent Night Market" initiative in Jiangsu province aims to provide innovative employment opportunities by extending job services to nighttime, addressing the mismatch in availability between job seekers and employers [1][2]. Group 1: Event Overview - The first event of the "Talent Night Market" was held in Nanjing, featuring over 50 employers offering 2,300 job positions across various sectors including software, smart manufacturing, and hospitality [1]. - The initiative is part of a broader campaign titled "Night Market Assists Beautiful Future," which will host over 350 events across the province in January and February [1]. Group 2: Job Categories - Job openings are categorized into three main types: 1. High-end technical positions in technology innovation, with salaries exceeding 10,000 yuan per month and annual salaries up to 450,000 yuan, targeting recent graduates and experienced professionals [2]. 2. Steady employment positions in manufacturing, aimed at ensuring continuous production during the Spring Festival [2]. 3. Flexible service roles in modern service industries, providing opportunities for job seekers facing employment difficulties [2]. Group 3: Additional Services - The human resources department plans to release a monthly activity calendar, leveraging major events to attract job seekers and provide comprehensive employment services [3]. - A "Skills Night School" will be established to enhance workers' skills, focusing on digital professions, AI, and traditional crafts, with a target of opening at least 300 training points and training over 60,000 individuals throughout the year [3].

Core Insights - Jiangsu Province has released its first batch of innovative drug and medical device products, including 149 products, with Suzhou contributing 60, accounting for 40% of the total [1] - Suzhou's selected products cover four key areas: Class 1 innovative drugs, Class 2 improved new drugs, Class 3 innovative medical devices, and Class 2 innovative medical devices, forming a comprehensive innovation product matrix [1] Group 1: Innovative Drugs - Suzhou has 14 Class 1 innovative drugs, addressing various treatment areas such as oncology, autoimmune diseases, metabolism, and infections [1] - Among these, Innovent Biologics' Ma Shidu Peptide Injection is the world's first dual receptor agonist for glucagon and GLP-1, targeting obesity-related metabolic issues [1] - Suzhou also includes 6 Class 2 improved new drugs, with BeiGene's Zebrutinib being the first domestically developed cancer drug approved in the U.S., projected to achieve global sales of 12.527 billion yuan in the first half of 2025, a 56.2% year-on-year increase [1] Group 2: Innovative Medical Devices - Suzhou has 25 Class 3 innovative medical devices and 15 Class 2 innovative medical devices, representing 69% and 43% of the provincial totals, respectively [1] - Peijia Medical's transcatheter aortic valve system offers a minimally invasive treatment option for heart valve disease, showcasing domestic technological advancements [2] - The implantable left ventricular assist device by Tongxin Medical is the first fully magnetic levitation artificial heart product approved in China, providing new hope for end-stage heart failure patients [2] Group 3: Industry Development and Support - Suzhou has over 4,200 biopharmaceutical companies, with an expected output value exceeding 250 billion yuan by 2025, supported by a complete industrial chain from early research to commercialization [2] - The local government is focusing on nurturing biopharmaceutical enterprises and enhancing policy support to promote the industrialization and clinical application of innovative results [2][3] - Market regulatory departments have implemented various service measures to accelerate the development and market entry of innovative products, including establishing a specialized review and approval service team [3][4]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 江蘇創新環保新材料有限公司 呈交日期: 2026年1月7日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02116 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | 本月底法定/註冊股本總額： HKD 15 ...

Group 1 - The core viewpoint of the article highlights the significant decline in motorcycle production and sales for Jiangsu Innovation Motorcycle Manufacturing Co., Ltd. in October 2025, with production down by 70.07% and sales down by 57.04% year-on-year [1] - The production volume for October 2025 was reported at 2,200 units, while the sales volume was 2,133 units, resulting in a production-sales rate of 96.95% and an inventory of 67 units [1] - The data is sourced from the China Automotive Industry (Motorcycle) Production and Sales Quick Report, compiled by Zhiyan Consulting, a leading industry consulting firm in China [1] Group 2 - The article references various listed companies in the motorcycle industry, including Qianjiang Motorcycle, Xinlong Health, Zhenghe Industrial, and others, indicating a broad market context [1] - Zhiyan Consulting has released a comprehensive report titled "2026-2032 China Motorcycle Industry Market Panorama Assessment and Development Strategy Analysis Report," which may provide further insights into industry trends and forecasts [1]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 江蘇創新環保新材料有限公司 呈交日期: 2025年12月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02116 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.01 HKD | | 15,000,000 | 本月底法定/註冊股本總額： HKD 1 ...